Zeria Pharmaceutical Co., Ltd. (TYO:4559)

Zeria Pharmaceutical Revenue

Zeria Pharmaceutical had revenue of 21.45B JPY in the quarter ending June 30, 2026, with 10.05% growth. This brings the company's revenue in the last twelve months to 91.12B, up 6.76% year-over-year. In the fiscal year ending March 31, 2026, Zeria Pharmaceutical had annual revenue of 89.16B with 2.12% growth.

• Revenue (ttm): 91.12B
• Revenue Growth: +6.76%
• P/S Ratio: 1.03
• Revenue / Employee: 52.13M
• Employees: 1,748
• Market Cap: 93.49B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	89.16B	1.85B	2.12%
Mar 31, 2025	87.31B	11.59B	15.30%
Mar 31, 2024	75.73B	7.34B	10.74%
Mar 31, 2023	68.38B	8.85B	14.87%
Mar 31, 2022	59.53B	4.09B	7.38%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 23, 2026

Data Sources Report a data error